 Surfactant replacement therapy single postventilatory dose reconstituted bovine surfactant preterm neonates respiratory distress syndrome final analysis multicenter double-blind trial comparison similar trials Surfactant-TA Study Group effects single dose surfactant TA premature neonates birth respiratory distress syndrome RDS multicenter double-blind clinical trial surfactant deficiency ultrasonographic evidence intracranial hemorrhage equal II Fifty-four patients surfactant mg phospholipid kilogram body weight patients air placebo hours life Treatment surfactant significant reduction severity RDS concomitant increase proportion neonates mild disease frequency pulmonary interstitial emphysema pneumothorax treated neonates control neonates vs vs frequency intracranial hemorrhage surfactant group control group vs neonates surfactant group vs categorized severity intracranial hemorrhage severity bronchopulmonary dysplasia surfactant group significant advantage Cochran-Mantel-Haenszel proportion neonates intracranial hemorrhage and/or bronchopulmonary dysplasia surfactant group control group neonates surfactant group control group differences groups respect frequency patent ductus arteriosus vs pulmonary hemorrhage vs enterocolitis vs sepsis vs retinopathy prematurity vs death vs treatment single-dose surfactant regimen study severity respiratory distress hours treatment major pulmonary morbidity intracranial hemorrhage premature neonates RDS Further studies treatment birth RDS use multiple dose surfactant additional benefits